Chapman Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$840K Hold
700
0.56% 54
2026
Q1
$644K Buy
700
+10
+1% +$10.1K 0.46% 66
2025
Q4
$742K Hold
690
0.51% 58
2025
Q3
$526K Buy
690
+436
+172% +$324K 0.36% 75
2025
Q2
$198K Buy
+254
New +$197K 0.17% 100
2024
Q4
$120K Buy
+156
New +$129K 0.1% 124

Other funds holding LLY

Chapman Financial Group's LLY Position: Q2 2026 in Review

Chapman Financial Group held its Eli Lilly (LLY) position steady in Q2 2026 at 700 shares worth $840K. The position accounts for 0.56% of the portfolio, ranked #54.

Chapman Financial Group first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Chapman Financial Group held 700 shares of Eli Lilly worth $840K as of Q2 2026.
  • Chapman Financial Group left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.56% of Chapman Financial Group's portfolio in Q2 2026, its #54 holding.
  • Chapman Financial Group first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Chapman Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.